EMAIL THIS PAGE TO A FRIEND

Journal of chromatography. A

Derivation of uncertainty functions from validation studies in biological fluids: application to the analysis of caffeine and its major metabolites in human plasma samples.


PMID 24925447

Abstract

Procedures for estimating the measurement uncertainty (MU) of the concentration of a given analyte in a sample are of major concern for analytical chemists. Unfortunately, it is still unclear how and why MU should be assessed. While several possibilities exist, an appropriate approach consists in using method validation data for the evaluation of MU. This was demonstrated by a validation study achieved in the framework of a clinical study related to caffeine in sports medicine, where the results were used for the evaluation of MU. After validation of the method developed using ultra-high pressure liquid chromatography-mass spectrometry for caffeine and its three main metabolites, accuracy profiles were built for each analyte. The first important conclusion is that the developed method was valid for all compounds and met the given specifications for the application (fit for purpose). Relevant estimates of combined standard uncertainty were computed to obtain uncertainty functions, which allow obtaining values of MU as a function of the concentration of the analyte. The great advantage of both uncertainty function and uncertainty profile is the development of a continuous model that enables easy calculation of the standard, expanded and relative expanded uncertainty at any concentration within the validation domain. In fact, the expanded uncertainty interval is assumed to contain 95% of all possible measurements, regardless of the concentration. Finally, the uncertainty function enables the determination of the lowest limit of quantification by selecting adequate acceptance limits, with the limit of quantification being defined as the point where the relative uncertainty equals the acceptance limit threshold. It has to be noted that further discussions remain mandatory to establish which criteria should be applied to define an adequate decision threshold, and the proposal afforded in this work may open new avenues in this direction.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

D5385
1,7-Dimethylxanthine, ~98%, solid
C7H8N4O2
C0100000
Caffeine, European Pharmacopoeia (EP) Reference Standard
C8H10N4O2
56396
Caffeine, certified reference material, TraceCERT®
C8H10N4O2
Y0000787
Caffeine for system suitability, European Pharmacopoeia (EP) Reference Standard
C8H10N4O2
1086006
Caffeine melting point standard, United States Pharmacopeia (USP) Reference Standard
C8H10N4O2
PHR1095
Caffeine Melting Point Standard, Pharmaceutical Secondary Standard; Certified Reference Material
C8H10N4O2
41019
Melting point standard 235-237°C, analytical standard
C8H10N4O2
75035
Mettler-Toledo Calibration substance ME 18872, Caffeine, analytical standard, for the calibration of the thermosystem 900, traceable to primary standards (LGC)
C8H10N4O2
T4500
Theobromine, ≥98.0%
C7H8N4O2
T0700000
Theobromine, European Pharmacopoeia (EP) Reference Standard
C7H8N4O2
42993
Theobromine, analytical standard
C7H8N4O2
T1633
Theophylline, anhydrous, ≥99%, powder
C7H8N4O2
PHR1023
Theophylline, Pharmaceutical Secondary Standard; Certified Reference Material
C7H8N4O2
1653004
Theophylline, certified reference material, United States Pharmacopeia (USP) Reference Standard
C7H8N4O2
T0800000
Theophylline, European Pharmacopoeia (EP) Reference Standard
C7H8N4O2
PHR1151
Theophylline melting point standard, Pharmaceutical Secondary Standard; Certified Reference Material
C7H8N4O2